Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Safety and efficacy of glucagon-like peptide-1 receptor agonists in patients with obstructive sleep apnea: a systematic review and meta-analysis of randomized controlled trials
has received financial remuneration from Alnylam, Amgen, AstraZeneca, Crinetics, Eli Lilly, Insulet, Kallyope, Metsera, Pfizer and Sanofi for consulting and from Novo Nordisk for speaking, and Mt
doi:10.1016/j.brs.2020.11.014
To develop heterobifunctional PROTACs recruiting the E3 ubiquitin ligases VHL or CRBN to RNF4, we used the established VHL- and CRBN-based E3 ligands and different linker moieties for proteasomal degradation of RNF4
US$ 28.44
US$ 21.12
US$ 22.98
US$ 28.50
